HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota
ABSTRACT Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono mety...
Gespeichert in:
Veröffentlicht in: | Biomedical chromatography 2012-04, Vol.26 (4), p.524-533 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 533 |
---|---|
container_issue | 4 |
container_start_page | 524 |
container_title | Biomedical chromatography |
container_volume | 26 |
creator | Alava, Pradeep Tack, Filip Laing, Gijs Du de Wiele, Tom Van |
description | ABSTRACT
Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/bmc.1700 |
format | Article |
fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_bmc_1700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BMC1700</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</originalsourceid><addsrcrecordid>eNp10E9PwjAYx_HGaATRxFdgevQyfNrRf0ddFEhAMWpMjEnTlQ6qbCPrUHn3joDcPPXyye9JvwidE-gSAHqV5rZLBMABahNQKgIJ5BC1gXIVxVKoFjoJ4QMAFKfiGLUoUcCAyTZ6H0xGSTRMJtH4CeeunpdTPHVfblEuc1fUuC5xXha-LitsquAKb3FYOutN7csC27kpZi7gdI3nq9wUeLaqce5tVaa-rM0pOsrMIriz3dtBL3e3z8kgGj30h8n1KLI92oOICEoyQhSVtgdCQaZSbgyTxHJmLaNGCGld81FnZBr3WCo4ZTHlJOMWHJ_GHXS53W0Oh1C5TC8rn5tqrQnoTSDdBNKbQA292NLlKs3ddA__ijQg2oJvv3Drf4f0zTjZDe68D7X72XtTfWouYsH0631fD5iUk7fHsR7Fv7NpfS0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Alava, Pradeep ; Tack, Filip ; Laing, Gijs Du ; de Wiele, Tom Van</creator><creatorcontrib>Alava, Pradeep ; Tack, Filip ; Laing, Gijs Du ; de Wiele, Tom Van</creatorcontrib><description>ABSTRACT
Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0269-3879</identifier><identifier>EISSN: 1099-0801</identifier><identifier>DOI: 10.1002/bmc.1700</identifier><identifier>PMID: 21905058</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>arsenic ; Arsenic - analysis ; Arsenic - metabolism ; Arsenicals - analysis ; Arsenicals - metabolism ; AsIII ; AsV ; Calibration ; Carcinogens - analysis ; Carcinogens - metabolism ; Chromatography, High Pressure Liquid - methods ; colon suspension ; DMAIII ; DMAV ; gastrointestinal ; Gastrointestinal Tract - microbiology ; Humans ; intestine ; Mass Spectrometry - methods ; Metagenome ; Methylation ; MMAIII ; MMAV ; nonequimolar ; Sensitivity and Specificity ; SHIME ; speciation</subject><ispartof>Biomedical chromatography, 2012-04, Vol.26 (4), p.524-533</ispartof><rights>Copyright © 2011 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</citedby><cites>FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbmc.1700$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbmc.1700$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21905058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alava, Pradeep</creatorcontrib><creatorcontrib>Tack, Filip</creatorcontrib><creatorcontrib>Laing, Gijs Du</creatorcontrib><creatorcontrib>de Wiele, Tom Van</creatorcontrib><title>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</title><title>Biomedical chromatography</title><addtitle>Biomed. Chromatogr</addtitle><description>ABSTRACT
Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley & Sons, Ltd.</description><subject>arsenic</subject><subject>Arsenic - analysis</subject><subject>Arsenic - metabolism</subject><subject>Arsenicals - analysis</subject><subject>Arsenicals - metabolism</subject><subject>AsIII</subject><subject>AsV</subject><subject>Calibration</subject><subject>Carcinogens - analysis</subject><subject>Carcinogens - metabolism</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>colon suspension</subject><subject>DMAIII</subject><subject>DMAV</subject><subject>gastrointestinal</subject><subject>Gastrointestinal Tract - microbiology</subject><subject>Humans</subject><subject>intestine</subject><subject>Mass Spectrometry - methods</subject><subject>Metagenome</subject><subject>Methylation</subject><subject>MMAIII</subject><subject>MMAV</subject><subject>nonequimolar</subject><subject>Sensitivity and Specificity</subject><subject>SHIME</subject><subject>speciation</subject><issn>0269-3879</issn><issn>1099-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E9PwjAYx_HGaATRxFdgevQyfNrRf0ddFEhAMWpMjEnTlQ6qbCPrUHn3joDcPPXyye9JvwidE-gSAHqV5rZLBMABahNQKgIJ5BC1gXIVxVKoFjoJ4QMAFKfiGLUoUcCAyTZ6H0xGSTRMJtH4CeeunpdTPHVfblEuc1fUuC5xXha-LitsquAKb3FYOutN7csC27kpZi7gdI3nq9wUeLaqce5tVaa-rM0pOsrMIriz3dtBL3e3z8kgGj30h8n1KLI92oOICEoyQhSVtgdCQaZSbgyTxHJmLaNGCGld81FnZBr3WCo4ZTHlJOMWHJ_GHXS53W0Oh1C5TC8rn5tqrQnoTSDdBNKbQA292NLlKs3ddA__ijQg2oJvv3Drf4f0zTjZDe68D7X72XtTfWouYsH0631fD5iUk7fHsR7Fv7NpfS0</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Alava, Pradeep</creator><creator>Tack, Filip</creator><creator>Laing, Gijs Du</creator><creator>de Wiele, Tom Van</creator><general>John Wiley & Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201204</creationdate><title>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</title><author>Alava, Pradeep ; Tack, Filip ; Laing, Gijs Du ; de Wiele, Tom Van</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4240-1721f11928c40790f9b6aa581c65cc52a778ce100ea8b345b76253261f6c0e6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>arsenic</topic><topic>Arsenic - analysis</topic><topic>Arsenic - metabolism</topic><topic>Arsenicals - analysis</topic><topic>Arsenicals - metabolism</topic><topic>AsIII</topic><topic>AsV</topic><topic>Calibration</topic><topic>Carcinogens - analysis</topic><topic>Carcinogens - metabolism</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>colon suspension</topic><topic>DMAIII</topic><topic>DMAV</topic><topic>gastrointestinal</topic><topic>Gastrointestinal Tract - microbiology</topic><topic>Humans</topic><topic>intestine</topic><topic>Mass Spectrometry - methods</topic><topic>Metagenome</topic><topic>Methylation</topic><topic>MMAIII</topic><topic>MMAV</topic><topic>nonequimolar</topic><topic>Sensitivity and Specificity</topic><topic>SHIME</topic><topic>speciation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alava, Pradeep</creatorcontrib><creatorcontrib>Tack, Filip</creatorcontrib><creatorcontrib>Laing, Gijs Du</creatorcontrib><creatorcontrib>de Wiele, Tom Van</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biomedical chromatography</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alava, Pradeep</au><au>Tack, Filip</au><au>Laing, Gijs Du</au><au>de Wiele, Tom Van</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota</atitle><jtitle>Biomedical chromatography</jtitle><addtitle>Biomed. Chromatogr</addtitle><date>2012-04</date><risdate>2012</risdate><volume>26</volume><issue>4</issue><spage>524</spage><epage>533</epage><pages>524-533</pages><issn>0269-3879</issn><eissn>1099-0801</eissn><abstract>ABSTRACT
Inorganic arsenic (iAs) has been classified as a type 1 carcinogen and has also been linked to several noncancerous health effects. Prior to 1995, the AsV methylation pathway was generally considered to be a detoxification pathway, but cellular and animal studies involving MMAIII (mono metyl arsonous acid) and DMAIII (dimethyl arsinous acid) have indicated that their toxicities meet or exceed that of iAs, suggesting an activation process. In addition, thiolated arsenic metabolites were observed in urine after oral exposure of inorganic arsenic in some studies, for which the toxicological profile was not yet fully characterized in human cells. Studies have revealed that microorganisms from the gut environment are important contributors to arsenic speciation changes. This presystemic metabolism necessitates the development of protocols that enable the detection of not only inorganic arsenic species, but also pentavalent and trivalent methylated, thiolated arsenicals in a gastrointestinal environment. We aim to study the biotransformation of arsenic (As) using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME). To be able to analyze the arsenicals resulting from biotransformation reactions occurring in this system, a method using liquid chromatography hyphenated to an inductively coupled plasma mass spectrometer (HPLC‐ICP‐MS) was developed. A Hamilton PRP‐X100 anion exchange column was used. The method allowed separation, identification and quantification of AsIII(arsenite), AsV(arsenate), DMAV(dimethylarsinicacid), MMAV(monomethylarsonicacid) and MMMTA (monomethylmonothioarsenate). Attempts to optimize the same method for also separating MMAIII and DMAIII did not succeed. These compounds could be successfully separated using a method based on the use of a Zorbax C18 column. The properties of the column, buffer strength, pH and polar nature of mobile phase were monitored and changed to optimize the developed methods. Linearity, sensitivity, precision, accuracy and resolution of both methods were checked. The combination of the two methods allowed successful quantification of arsenic species in suspensions sampled in vitro from the SHIME reactor or in vivo from the human colon and feces. Copyright © 2011 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>21905058</pmid><doi>10.1002/bmc.1700</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-3879 |
ispartof | Biomedical chromatography, 2012-04, Vol.26 (4), p.524-533 |
issn | 0269-3879 1099-0801 |
language | eng |
recordid | cdi_crossref_primary_10_1002_bmc_1700 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | arsenic Arsenic - analysis Arsenic - metabolism Arsenicals - analysis Arsenicals - metabolism AsIII AsV Calibration Carcinogens - analysis Carcinogens - metabolism Chromatography, High Pressure Liquid - methods colon suspension DMAIII DMAV gastrointestinal Gastrointestinal Tract - microbiology Humans intestine Mass Spectrometry - methods Metagenome Methylation MMAIII MMAV nonequimolar Sensitivity and Specificity SHIME speciation |
title | HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T17%3A40%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HPLC-ICP-MS%20method%20development%20to%20monitor%20arsenic%20speciation%20changes%20by%20human%20gut%20microbiota&rft.jtitle=Biomedical%20chromatography&rft.au=Alava,%20Pradeep&rft.date=2012-04&rft.volume=26&rft.issue=4&rft.spage=524&rft.epage=533&rft.pages=524-533&rft.issn=0269-3879&rft.eissn=1099-0801&rft_id=info:doi/10.1002/bmc.1700&rft_dat=%3Cwiley_cross%3EBMC1700%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21905058&rfr_iscdi=true |